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Nephronophthisis is a heterogenetic autosomal recessive
disorder associated with multiple developmental
abnormalities, including cystic kidney disease and retinal
degeneration. Retinal dystrophies, in particular the X-linked
forms, are believed to represent a distinct group of
hereditary diseases; however, their genetic complexity and
overlap with other syndromic diseases is increasingly
apparent. In this study, we report that depletion of retinitis
pigmentosa GTPase regulator (RPGR) during zebrafish
embryogenesis causes developmental changes
indistinguishable from the abnormalities caused by the
depletion of nephrocystin-5 or nephrocystin-6. However,
RPGR did not directly interact with either gene product.
RPGR-interacting protein 1 was found to act as an adaptor
connecting RPGR to nephrocystin-6, thereby linking it to the
nephronophthisis protein network. This interaction was
abolished by truncating mutations (c.1107delA) of the
interacting protein. Our findings underline the importance of
the interplay between the two protein networks, suggesting
a phenotypic modulation in both retinitis pigmentosa and
nephronophthisis.
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Nephronophthisis (NPHP), an autosomal recessive cystic
kidney disease with an estimated prevalence of 1 in 100,000,
represents the most frequent genetic cause of renal insuffi-
ciency in the first decades of life. Hitherto, mutations in nine
genes (NPHP1 through 9) have been identified to cause the
disease.1,2 In 410% of cases, NPHP is associated with
extrarenal symptoms, most frequently retinal degeneration.
Two distinct forms of retinal manifestations are typically
found in patients with NPHP mutations, namely Leber
congenital amaurosis (LCA) with blindness or severe visual
impairment before the first year of life,3 and retinitis
pigmentosa with the onset of night blindness at childhood,
followed by progressive loss of peripheral vision and central
acuity.4 The association between retinal and renal phenotype
is also known as the Senior–Løken syndrome. Truncating
mutations in both NPHP5 (IQCB1) and NPHP6 (CEP290)
lead to Senior–Løken syndrome;5 however, hypomorphic
NPHP6 mutations are frequently associated with isolated
LCA,6 suggesting that interactions with other proteins define
the localization and severity of the disease. Both gene
products, nephrocystin-5 and nephrocystin-6, associate with
RPGR (retinitis pigmentosa GTPase regulator),5 whereas
nephrocystin-6 additionally interacts with RPGRIP1 (RPGR-
interacting protein 1).7 Mutations of these proteins lead to
retinitis pigmentosa and LCA, respectively. Although patients
affected by mutations in the RPGR or RPGRIP1 gene locus
have not been reported to show any renal phenotype,
RPGRIP1-like protein (RPGRIP1L) is known to be frequently
mutated in patients with Meckel–Gruber and Joubert
syndrome, a cerebro-oculo-renal variant of NPHP.8–10
These findings prompted us to characterize the role of
RPGR in the NPHP protein network. Mutations in RPGR
lead to X-linked and simplex forms of retinitis pigmentosa;
some patients additionally suffer from hearing dysfunction
and respiratory infections.11,12 Morpholino oligonucleotide
(MO)-mediated knockdown of RPGR in zebrafish caused
developmental defects described for depletion of ciliary
proteins, including the formation of pronephric cysts.
Combined knockdown of both NPHP6 and RPGR synergis-
tically augmented the observed defects. Although we have
previously reported that NPHP5 associates with NPHP6,13
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we could not detect a direct interaction between either
NPHP5 or NPHP6 with RPGR. Instead, we identified
RPGRIP1 as the protein that links NPHP6 to the RPGR-
containing protein network. These findings implicate that
mutations of RPGR may contribute to the manifestations
observed in NPHP, including cystic kidney disease.
RESULTS
Depletion of zebrafish RPGR causes developmental changes
consistent with a ciliopathy
We identified the zebrafish homolog of human RPGR
(NM_001034853.1) on chromosome 9 (transcript ID: EN
SDART00000079095; protein ID: ENSDARP00000073550;
according to Ensembl release 54 May 2009, RefSeq
XM_694906.3), and targeted the start codon by an antisense
MO to block the translational start site (Figure 1a).
Knockdown of zRPGR caused significant developmental
changes, including an abnormal and shortened body
curvature (Figure 1b), similar to changes obtained by deple-
tion of NPHP5 and NPHP6 (Supplementary Figure S1).13,14
Cerebral abnormalities included a thin mid-to-hindbrain
boundary and hydrocephalus (Figure 1c). Eyes were present,
but were smaller when compared with wild-type embryos
(Figure 1d). Renal cysts occurred in 6% of the embryos
injected with MO concentrations between 0.025 and
0.1mmol/l, but increased to 20–25% at MO concentrations
between 0.25 and 0.75mmol/l (Figure 1e and data not
shown). This dose dependency is similar to observations in
other knockdowns of NPHP proteins.13,15
The combined knockdown of zRPGR and zNPHP6 during
zebrafish development is synergistic
As the phenotypes after knockdown of zRPGR resemble embryos
treated with zNPHP6 MO,13 we compared single-injected
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Figure 1 |Knockdown of RPGR in zebrafish embryos causes abnormal body curvature, cerebral abnormalities, underdeveloped
eyes and pronephric cysts. (a) Zebrafish RPGR gene comprises 5229 base pairs and consists of 14 exons. An antisense morpholine (RPGR
MO) was designed that covers base pairs 1–25 to block the translational start site. (b) RPGR MO zebrafish embryos exhibited variable
degrees of dysmorphy. Zebrafish embryos were analyzed at 50–55 h after fertilization (hpf). A representative body curvature defect is shown.
Dysmorphy rates increase in a dose-dependent manner (CTL = Control) (c) Cerebral abnormalities in RPGR MO zebrafish embryos were
characterized by hydrocephalus and a thin mid-to-hindbrain boundary as a consequence of misfolding of the cerebellum and/or
hydrocephalus formation (arrow). The hydrocephalus incidence (bar graph) was scored at 50–55 hpf in surviving embryos injected with
0.05–0.75mmol/l RPGR morpholino. (d) Knockdown of RPGR further resulted in smaller and underdeveloped eyes (arrowheads).
(e) Pronephric cyst formation (circle) occurred in RPGR MO zebrafish embryos. MO, morpholino oligonucleotide; RPGR, retinitis pigmentosa
GTPase regulator; WT, wild type.
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embryos with the double knockdown of zNPHP6 and zRPGR,
using an established morpholino against zNPHP6 13,14 Although
single-injected embryos showed only minor defects in body
curvature, cerebral structures and cyst formation at low
morpholino concentrations (0.05mmol/l for either zRPGR or
zNPHP6; Figure 2a and c), embryos treated with both
morpholinos at the same concentration showed a significant
increase in the presence of dysmorphies (Po0.0008 and
Po0.0001, respectively, Fisher’s exact test for double knock-
down vs single injections of RPGR and NPHP6, respectively)
(Figure 2b) and pronephric cysts (highlighted by green
fluorescent protein (GFP) expression in wt1b::GFP transgenic
background; Po0.001; Figure 2c and d). The frequency of
hydrocephalus formation was not altered by the combined
knockdown (data not shown), suggesting a different mode of
interaction between RPGR and NPHP6 during cerebral
development.
RPGR does not physically interact with NPHP6 and NPHP5
It was previously reported that both NPHP6 and NPHP5
associate with RPGR.5,7 When we tested the physical
interaction in coimmunoprecipitation experiments, we were
unable to detect an interaction in HEK 293T cells, using
overexpressed RPGR and fragments of NPHP6 covering the
entire coding region (data not shown). We have previously
found that NPHP5 recognizes a fragment of NPHP6
spanning amino acids 665–1288,13 which we confirmed using
a polyclonal antibody generated against NPHP5 (Figure 3a).
As mutations in NPHP5, NPHP6 and RPGR lead to very
similar retinal phenotypes, we hypothesized that NPHP5
could connect RPGR to NPHP6. We therefore determined
whether NPHP5 interacts with RPGR. However, even in HEK
293T cells, overexpressing both proteins at high levels, we
were unable to detect an interaction between both proteins,
using standard immunoprecipitation assays (Figure 3b).
These observations indicated that the reported interactions
between RPGR and NPHP5 or NPHP6 are likely indirect,
suggesting that another linker protein recruits these proteins
in a common protein complex.
RPGRIP1 connects RPGR to NPHP6
RPGRIP1 was originally identified as a binding partner of
RPGR,16 and subsequently shown to cause LCA with rapid
and progressive vision loss.17,18 RPGRIP1 is known to
interact with RPGR through a C-terminal RPGR-interacting
domain (RID, Figure 4a) and with nephrocystin-4 through its
C2 domain.19 We found that RPGRIP1 interacts with a
fragment of nephrocystin-6 spanning amino acids 1250–2005
(Figure 4b). Nephrocystin-6 was not able to precipitate
RPGR directly (Figure 4c); however, in the presence of
RPGRIP1, we were able to pull the complex consisting of
RPGR, RPGRIP1, and NPHP6. RPGRIP1 exists in different
splicing variants.20 We analyzed the interaction between
NPHP6 and the protein product of the truncated isoform
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Figure 2 | The combined knockdown of NPHP6 and RPGR increases body dysmorphy and the occurrence of cyst formation. Both
(a, b) body curvature defects and (c, d) pronephric cyst formation were observed at low frequency in zebrafish embryos injected with
a low concentration of RPGR MO or NPHP6 MO (0.05mmol/l each). (Panels a, c) Representative phenotypes of body curvature defects and
hydrocephalus formation (arrows) in comparison with wild-type (WT) for RPGR MO, NPHP6 MO, and double morpholino injected embryos at
55 hpf are shown. Cystic aberration of the pronephros is evident by dilated Bowman’s capsule and adjacent proximal tubules (asterisk in
panel c), highlighted by wt1b-GFP expression. (Panels b, d) The combined knockdown of RPGR and NPHP6 at concentrations of 0.05mmol/l
per morpholino resulted in a significant increase of observed body curvature defects and cysts. Percentages of scores phenotypes are
shown; total scores of embryos are indicated above the bars. GFP, green fluorescent protein; MO, morpholino oligonucleotide; NPHP,
nephronophthisis; RPGR, retinitis pigmentosa GTPase regulator; CTL, control; *Po0.0008 (b) or Po0.0001 (d), respectively.
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rpgrip1b (RPGRIP1 dRID), which lacks both the C2-C
domain and the RID (Figure 4a). In coimmunoprecipitation
experiments, this truncated form still interacted with
nephrocystin-6, but longer functioned as a linker between
nephrocystin-6 and RPGR (Figure 4c).
Most patient mutations of RPGRIP1 are located in the C2
domain and RID,21 therefore affecting the interaction
between RPGRIP1 and RPGR.22 We generated a truncating
mutation (c.1107delA) located upstream in the coiled-coil
domain as described by Dryja et al.17 As expected, this
shortened form is no longer able to bind to RPGR
(Supplementary Figure S2), as it lacks the C2 domain/RID.
In addition, this truncation was found to be unable to recruit
RPGRIP1 to NPHP6, suggesting that the coiled-coil domains
might be important for the recruitment process. These
findings highlight the fact that mutations in the linker
molecule RPGRIP1 interfere not only with RPGR but also
with NPHP6 interactions.
DISCUSSION
Congenital retinal dystrophies manifest in distinct clinical
patterns. LCA, the most severe retinopathy, is characterized
by blindness or severe visual impairment before the age of
1 year,23 whereas congenital retinal dystrophies associated
with NPHP (Senior–Løken syndrome) typically show a
milder clinical course. However, mutations of either NPHP5
or NPHP6 are associated with retinal abnormalities in 100%.
Nephrocystins appear to contribute to a multimeric protein
network that localizes to the connecting cilium in photo-
receptors,24 a subcellular compartment that links the light-
sensitive outer segment to the inner segment (see also
Supplementary Figure S3). Interactions between the nephro-
cystins and the family of retinitis pigmentosa GTPase
regulator-related proteins have been reported, and both
nephrocytin-5 and nephrocystin-6 associate with RPGR in
mammalian retinal extracts.7,14 RPGRIP1 is a scaffolding
protein that anchors RPGR to the cilium and binds
nephrocystin-4 through its C2 domain.19 The NPHP8 gene
product RPGRIP1L, a protein closely related to RPGRIP1,
also interacts with RPGR. Loss-of-function mutations of
RPGRIP1L cause Joubert and Meckel–Gruber syndrome,
whereas hypomorphic mutations of RPGRIP1L that only
diminish the affinity of RPGRIP1L for RPGR, have recently
been shown to promote retinal degeneration.25 RPGRIP1L-
null mice show a phenotypic overlap with OFD1 (oral-facial-
digital type 1) knockout mice, including renal cyst development
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Figure 3 | Endogenous nephrocystin-5 interacts with nephrocystin-6 but not directly with RPGR. (a) Endogenous NPHP5 interacts with
a NPHP6 fragment spanning amino acids 665–1288. FLAG-tagged fragments of NPHP6 were expressed in mammalian cells (HEK 293T); the
numbers refer to the amino acids of NPHP6. After immunoprecipitation with an anti-NPHP5 antibody (above), the NPHP6 fragment,
spanning amino acids 665–1288, was present in the precipitates, but not the NPHP6 fragment between amino acids 1 and 695. After
immunoprecipitation with an anti-FLAG antibody (below), endogenous NPHP5 was detected in the NPHP6 fragment precipitate between
amino acids 665 and 1288 but not in the NPHP6 fragment precipitate, spanning amino acids 1–695. (b) NPHP5 does not interact with RPGR.
YFP-tagged RPGR was coexpressed with both full-length and three fragments of V5-tagged NPHP5 in mammalian cells (HEK 293T); the
numbers refer to the amino acids of NPHP5. After immunoprecipitation with an anti-V5 antibody, in none of the assays, was RPGR present in
the precipitates. It must be noted that the anti-GFP antibody also detects the YFP-tag. GFP, green fluorescent protein; YFP, yellow-
fluorescent protein; NPHP, nephronophthisis; RPGR, retinitis pigmentosa GTPase regulator.
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and other features of ciliary dysfunction.26 OFD1 (causing
X-linked Joubert syndrome and OFD1 syndrome with
cystic kidneys in humans) was shown to interact and
colocalize with lebercilin (causing LCA in humans) at the
ciliary basal body.27
In this study, we provide further evidence for the
functional relationship between the nephrocystin and RPGR
protein networks. We show that RPGRIP1 links NPHP6 to
RPGR through its RID. In addition, our zebrafish knock-
down experiments demonstrate the overlapping functions of
NPHP6 and RPGR during normal pronephros development.
The phenotypic similarities (also see Supplementary Figure
S1) and the significant increase of cystic pronephric aberra-
tions in the combined knockdown with NPHP6 strongly
suggest that RPGR might have a causative role in the
pathogenesis of NPHP, either as a confounding factor or as a
novel, hitherto unidentified NPHP gene. Our study under-
lines the importance of RPGRIP1 in both NPHP and retinal
dystrophy.
MATERIALS AND METHODS
Reagents and plasmids
YFP-, V5-, and FLAG-tagged full-length and truncated versions of
NPHP5 and NPHP6 were used as described previously.13 RPGR and
RPGRIP1dRID (NCBI accession number BC016092.1) were ampli-
fied from a mouse embryonic cDNA library using standard cloning
techniques and subsequently cloned into the desired expression
vectors (based on pcDNA6). RPGRIP1wRID was synthesized by
Geneart AG (Regensburg, Germany) based on NCBI accession
number NM 020366. Antibodies used in this study included mouse
M2 antibody to FLAG (Sigma, Munich, Germany), mouse antibody
to V5 (Serotec, Raleigh, NC, USA), and mouse antibody to GFP
(MBL, Woburn, MA, USA).
Zebrafish lines and manipulations
Zebrafish manipulations and analysis were performed as described
recently.13,28 In brief, fertilized eggs of wild-type AB/TL or
wt1b::GFP transgenic strain (the latter expressing GFP in the
glomerulus and proximal tubules under the control of a wt1b
translation initiation site29 were microinjected with 4.6 nl of
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Figure 4 |RPGPIP1 acts as an adaptor between RPGR and nephrocystin-6. (a) Model of the RPGRIP1 isoforms with putative domains.
The two isoforms used in this study are depicted. It must be noted that RPGRIP1dRID lacks the C2 domain and RID contained in the
RPGRIP1wRID form. (b) RPGRIP1 interacts with the NPHP6 fragment spanning amino acids 1250–2005. FLAG-tagged RPGRIP1wRID was
coexpressed with V5-tagged fragments of NPHP6 in mammalian cells (HEK 293T); the numbers refer to the amino acids of NPHP6. After
immunoprecipitation with an anti-FLAG antibody, the NPHP6 fragment, spanning amino acids 1250–2005, was present in the precipitates.
None of the other NPHP6 fragments were detected in the RPGRIP1 precipitates. (c) RPGR interacts with NPHP6 through RPGRIP1. The V5-
tagged fragment of NPHP6 between amino acids 1250 and 2005 was coexpressed with different combinations of RPGRIP1 and RPGR in
mammalian cells (HEK 293T): First, there were three single coexpressions with RPGIP1 in an isoform including its RPGR-interacting domain
(wRID), in an RPGRIP1 isoform without the RPGR-interacting domain (dRID) and with RPGR, respectively. Second, there were two double
coexpressions with both RPGR and RPGRIP1, in the wRID isoform and the dRID isoform, respectively. After immunoprecipitation with an
anti-V5 antibody, RPGRIP1 was present in all precipitates of assays with RPGRIP1 expression, regardless of the isoform. RPGR was only
detected in the precipitates in the assay with coexpression of the wRID isoform of RPGRIP1, suggesting that RPGRIP1, including the RPGR-
interacting domain, is necessary for RPGR binding to NPHP6. *Heavy chain (hc) of immunoglobulins. NPHP, nephronophthisis; RPGR, retinitis
pigmentosa GTPase regulator; RPGRIP1, RPGR-interacting protein 1.
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injection solution at the 1–2 cell stage with antisense morpholino
(Gene Tools LLC, Philomath, OR, USA) diluted in 200mmol/l KCL,
0.1% Phenol Red, and 10mmol/l HEPES (pH 7.5). The following
morpholinos were used: zRPGR-MO1 (50-CTGTGTGATACC
AAAAATAAGGCAT-30), zNPHP5 (MO5: 50-TCAAATCTGAATAC
CTGAGGAGGTC-30), and zNPHP6 (MO6: 50-TGAAAAGTTGCAC
CTACAGAGGGTC-30); the latter two were described previously.13,14
Characterization of the antibody
We used a bacterially expressed truncation of nephrocystin-5
spanning amino acids 1–195 tagged with glutathion S-transferase
for rabbit immunization (Eurogentec, Cologne, Germany). The
antibody to nephrocystin-5 was isolated from the serum by affinity
purification using the same but MBP-tagged fragment (maltose
binding protein) of nephrocystin-5. The quality of the antibody was
controlled by western blotting using overexpressed FLAG-tagged
and V5-tagged nephrocystin-5.
Coimmunoprecipitation
Coimmunoprecipitation experiments were carried out as described
previously.13 HEK 293T cells were either transiently transfected or
endogenous protein was precipitated from lysates of three pooled
confluent dishes (diameter: 10 cm). For the retinal ARPE cell line,
two dishes were pooled for endogenous immunoprecipitation.
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Figure S1. Depletion of RPGR, NPHP5 and NPHP6 result in similar
abnormalities of body curvature, brain and eye structures.
Figure S2. The patient mutation c.1107delA in RPGRIP1 disrupts the
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